Remote Myocardial Ischemic Preconditioning in Humans

Completed · Not applicable

Conditions studied: Coronary Artery Ischemia

In brief

Ischemic preconditioning (IP) has been shown in animal studies to increase the myocardial tolerance to subsequent ischemia. Our primary hypothesis is that remote IP reduces myocardial ischemic injury during PCI.

Key facts

Study ID

NCT00588042

Run by

Mayo Clinic

People needed

156

Starts

2007-10-01

Expected to finish

2009-06-01

Last updated by the study team

2019-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients will be eligible for randomization if they meet the following criteria:
• Age ≥ 18 years
• Clinically indicated elective or urgent PCI

You may not qualify if…

• Patients will be ineligible for the study if one or more of the following conditions exist:
• Pre-PCI Troponin T ≥ 0.03
• Systemic hypotension (systolic <90 mmHg) or cardiogenic shock
• Presence of an arteriovenous fistula or lymphedema of either arm
• Currently enrolled in other active cardiovascular investigational studies
• Severe endocrine, hepatic, renal, disorders
• Pregnancy or lactation
• Inability to provide consent
• Federal Medical Center inmates
• Inability or unwillingness to provide informed consent

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.